European Innovation Council

Established in 2020, the European Innovation Council supports innovative startups and researchers with promising ideas, focusing on early-stage companies with positive environmental, social, or governance impacts. It co-invests alongside private investors.

David Malo Jean

Director

Past deals in MENA

Innoventric

Series B in 2024
Innoventric is an Israeli medical device company specializing in percutaneous solutions for Tricuspid Regurgitation and right heart disease. Founded in 2017, the company's flagship product is the Trillium™ technology, designed to treat Tricuspid Valve Regurgitation through functional valve replacement using Cross-Caval anchoring and a unique multi-valve design.

MediWound

Grant in 2024
MediWound Ltd. is an integrated biopharmaceutical company based in Yavne, Israel, that specializes in developing, manufacturing, and commercializing innovative therapeutic products for severe burns and chronic wounds. Founded in 2000, the company is known for its flagship product, NexoBrid, which is an FDA-approved biopharmaceutical designed for the removal of eschar in adults with deep partial- and full-thickness thermal burns, offering a less invasive alternative to surgical interventions. MediWound also advances other product candidates, including EscharEx, which has completed Phase II clinical trials for the debridement of chronic and hard-to-heal wounds, and MWPC003 for connective tissue disorders. The company aims to address significant unmet medical needs in these areas and improve patient outcomes.

MediWound

Post in 2024
MediWound Ltd. is an integrated biopharmaceutical company based in Yavne, Israel, that specializes in developing, manufacturing, and commercializing innovative therapeutic products for severe burns and chronic wounds. Founded in 2000, the company is known for its flagship product, NexoBrid, which is an FDA-approved biopharmaceutical designed for the removal of eschar in adults with deep partial- and full-thickness thermal burns, offering a less invasive alternative to surgical interventions. MediWound also advances other product candidates, including EscharEx, which has completed Phase II clinical trials for the debridement of chronic and hard-to-heal wounds, and MWPC003 for connective tissue disorders. The company aims to address significant unmet medical needs in these areas and improve patient outcomes.

NanoScent

Convertible Note in 2023
NanoScent is an Israeli sensor technology startup founded in 2017 that develops nanotechnology-based sensors for real-time detection of hydrogen impurities, gases, and volatile organic compounds. The company focuses on climate tech sensing and offers systems for monitoring hydrogen quality across the supply chain—from production to storage and refueling stations. Its flagship product, VOCID H2Confirm, provides in-line monitoring of hydrogen purity and VOCs with real-time alerts. NanoScent's technology supports applications in safety, quality control, and environmental monitoring. The company is headquartered in Misgav, Israel.

Sensoneo

Series A in 2023
Sensoneo is a global provider of enterprise‑grade smart waste management solutions that help cities and businesses reduce costs and environmental impact. The company combines in‑house ultrasonic sensors—Single, Double, Quatro, and patent‑pending Micro‑sensors—with advanced software that delivers real‑time monitoring, analytics, route planning, and vehicle load optimization. By enabling data‑driven decisions, Sensoneo’s platform can cut waste‑collection costs by at least 30 % and lower carbon emissions by up to 60 %. Its solutions are deployed in numerous locations across Europe, North America, South America, the Middle East, Australia, and New Zealand, and include incentive programs that encourage waste reduction and streamline the entire waste lifecycle.

Alesi Surgical

Grant in 2022
Alesi Surgical Ltd. is a company based in Cardiff, United Kingdom, specializing in the development and commercialization of laparoscopic surgical smoke handling systems. Founded in 2009 as a spin-out from the Welsh Institute for Minimal Access Therapy, Alesi Surgical focuses on creating products that enhance the safety, efficiency, and outcomes of surgical procedures. Its innovative tools are portable and suitable for both laparoscopic and robot-assisted surgeries, utilizing electrostatic precipitation technology to eliminate surgical smoke and maintain a clear visual field during operations. The company distributes its products to hospitals across Europe, the Middle East, New Zealand, and Australia, leveraging its access to experienced surgeons and surgical trainers to identify challenges in surgical procedures and design effective solutions.

Restore Medical

Grant in 2022
Restore Medical develops a device-based therapy for congestive heart failure. Its product, ContraBand, is a catheter-delivered implant in the pulmonary arteries designed to improve patient quality of life and reduce hospital readmission rates.

Indoor Robotics

Series A in 2022
Founded in 2018, Indoor Robotics designs and develops Tando, an AI-powered patrol drone for indoor security and inspection missions. Its unique features include independent AI-based navigation and patented ceiling docking, providing real-time coverage with predictive analysis to minimize false alarms.

Filterlex Medical

Venture Round in 2021
Filterlex Medical is a medical device company focused on cardiovascular embolic protection. It develops embolic protection devices to reduce the risk of stroke and other embolic complications during catheter-based structural heart procedures, including transcatheter aortic valve implantation. Its CAPTIS full-body embolic protection device is designed for intuitive deployment and retrieval and is compatible with multiple catheter sizes, enabling integration into existing workflows. The company aims to improve patient safety during minimally invasive heart valve replacement procedures. It was founded in 2015 and is based in Yokneam, Israel.

Colospan

Venture Round in 2021
Colospan is a medical device company specializing in colorectal surgery. Founded in 2010, it develops innovative products to prevent anastomotic leaks and diverting colonic stomas during intestinal surgeries.

Innoventric

Series A in 2021
Innoventric is an Israeli medical device company specializing in percutaneous solutions for Tricuspid Regurgitation and right heart disease. Founded in 2017, the company's flagship product is the Trillium™ technology, designed to treat Tricuspid Valve Regurgitation through functional valve replacement using Cross-Caval anchoring and a unique multi-valve design.

Healium Medical

Grant in 2021
Healium Medical develops a contactless ultrasound ablation system for atrial fibrillation that enables circumferential pulmonary vein isolation with real-time lesion monitoring. The system uses an over-the-wire catheter with a proprietary ultrasound transducer positioned at the pulmonary vein ostium to deliver rapid, non-contact ablation and provide immediate feedback on lesion formation. The solution aims to simplify the procedure, shorten procedure time, and improve efficacy compared with traditional tissue-contact approaches. Founded in 2017, the company is headquartered in Yokneam Illit, Israel.

Healium Medical

Venture Round in 2021
Healium Medical develops a contactless ultrasound ablation system for atrial fibrillation that enables circumferential pulmonary vein isolation with real-time lesion monitoring. The system uses an over-the-wire catheter with a proprietary ultrasound transducer positioned at the pulmonary vein ostium to deliver rapid, non-contact ablation and provide immediate feedback on lesion formation. The solution aims to simplify the procedure, shorten procedure time, and improve efficacy compared with traditional tissue-contact approaches. Founded in 2017, the company is headquartered in Yokneam Illit, Israel.

Sensoneo

Venture Round in 2021
Sensoneo is a global provider of enterprise‑grade smart waste management solutions that help cities and businesses reduce costs and environmental impact. The company combines in‑house ultrasonic sensors—Single, Double, Quatro, and patent‑pending Micro‑sensors—with advanced software that delivers real‑time monitoring, analytics, route planning, and vehicle load optimization. By enabling data‑driven decisions, Sensoneo’s platform can cut waste‑collection costs by at least 30 % and lower carbon emissions by up to 60 %. Its solutions are deployed in numerous locations across Europe, North America, South America, the Middle East, Australia, and New Zealand, and include incentive programs that encourage waste reduction and streamline the entire waste lifecycle.

Colospan

Grant in 2021
Colospan is a medical device company specializing in colorectal surgery. Founded in 2010, it develops innovative products to prevent anastomotic leaks and diverting colonic stomas during intestinal surgeries.

PlasFree

Grant in 2021
PlasFree develops ClearPlasma, a medical device that modifies human plasma to enhance its coagulating properties. This improves treatment for massive bleeding by removing fibrinolytic proteins that dissolve blood clots. Headquartered in Nazareth, Israel, PlasFree aims to revolutionize bleeding treatment globally.

PlasFree

Venture Round in 2021
PlasFree develops ClearPlasma, a medical device that modifies human plasma to enhance its coagulating properties. This improves treatment for massive bleeding by removing fibrinolytic proteins that dissolve blood clots. Headquartered in Nazareth, Israel, PlasFree aims to revolutionize bleeding treatment globally.

MYSPHERA

Venture Round in 2021
MYSPHERA SL is a company based in Paterna, Spain, that specializes in developing location and process visibility solutions for the healthcare sector using Internet of Things (IoT) technology and real-time location systems (RTLS). Established in 2012, MYSPHERA offers a range of IoT devices and applications designed to enhance patient care and operational efficiency in acute care hospitals, senior living facilities, and patient homes. Its solutions include tracking systems for residents and nursing services, as well as alerts for patients. The company also provides various web applications, such as MYHOSPITAL, MYNURSING, and MYLOCS, which assist healthcare professionals and administrators in managing services effectively. By delivering actionable insights through smart sensors, MYSPHERA aims to improve patient outcomes and optimize resource management across healthcare organizations in Europe, the Middle East, and Latin America.

MYSPHERA

Grant in 2021
MYSPHERA SL is a company based in Paterna, Spain, that specializes in developing location and process visibility solutions for the healthcare sector using Internet of Things (IoT) technology and real-time location systems (RTLS). Established in 2012, MYSPHERA offers a range of IoT devices and applications designed to enhance patient care and operational efficiency in acute care hospitals, senior living facilities, and patient homes. Its solutions include tracking systems for residents and nursing services, as well as alerts for patients. The company also provides various web applications, such as MYHOSPITAL, MYNURSING, and MYLOCS, which assist healthcare professionals and administrators in managing services effectively. By delivering actionable insights through smart sensors, MYSPHERA aims to improve patient outcomes and optimize resource management across healthcare organizations in Europe, the Middle East, and Latin America.

Indoor Robotics

Venture Round in 2021
Founded in 2018, Indoor Robotics designs and develops Tando, an AI-powered patrol drone for indoor security and inspection missions. Its unique features include independent AI-based navigation and patented ceiling docking, providing real-time coverage with predictive analysis to minimize false alarms.

Innoventric

Grant in 2021
Innoventric is an Israeli medical device company specializing in percutaneous solutions for Tricuspid Regurgitation and right heart disease. Founded in 2017, the company's flagship product is the Trillium™ technology, designed to treat Tricuspid Valve Regurgitation through functional valve replacement using Cross-Caval anchoring and a unique multi-valve design.

NanoScent

Series A in 2020
NanoScent is an Israeli sensor technology startup founded in 2017 that develops nanotechnology-based sensors for real-time detection of hydrogen impurities, gases, and volatile organic compounds. The company focuses on climate tech sensing and offers systems for monitoring hydrogen quality across the supply chain—from production to storage and refueling stations. Its flagship product, VOCID H2Confirm, provides in-line monitoring of hydrogen purity and VOCs with real-time alerts. NanoScent's technology supports applications in safety, quality control, and environmental monitoring. The company is headquartered in Misgav, Israel.

Sensoneo

Grant in 2020
Sensoneo is a global provider of enterprise‑grade smart waste management solutions that help cities and businesses reduce costs and environmental impact. The company combines in‑house ultrasonic sensors—Single, Double, Quatro, and patent‑pending Micro‑sensors—with advanced software that delivers real‑time monitoring, analytics, route planning, and vehicle load optimization. By enabling data‑driven decisions, Sensoneo’s platform can cut waste‑collection costs by at least 30 % and lower carbon emissions by up to 60 %. Its solutions are deployed in numerous locations across Europe, North America, South America, the Middle East, Australia, and New Zealand, and include incentive programs that encourage waste reduction and streamline the entire waste lifecycle.

Sensoneo

Venture Round in 2020
Sensoneo is a global provider of enterprise‑grade smart waste management solutions that help cities and businesses reduce costs and environmental impact. The company combines in‑house ultrasonic sensors—Single, Double, Quatro, and patent‑pending Micro‑sensors—with advanced software that delivers real‑time monitoring, analytics, route planning, and vehicle load optimization. By enabling data‑driven decisions, Sensoneo’s platform can cut waste‑collection costs by at least 30 % and lower carbon emissions by up to 60 %. Its solutions are deployed in numerous locations across Europe, North America, South America, the Middle East, Australia, and New Zealand, and include incentive programs that encourage waste reduction and streamline the entire waste lifecycle.

Polymertal

Grant in 2020
Polymertal Ltd is an innovative company based in Haifa, Israel, specializing in advanced metal plating processes that enable the production of lightweight hybrid metal-polymer components. Founded in 2007, Polymertal serves a diverse range of industries, including defense, communications, aviation, and space. The company offers a comprehensive suite of products and solutions, such as hybrid components, electronic cases, hybrid molds, and hybrid RF elements. Its proprietary technology allows for the effective bonding of metals and polymers, making it possible to replace traditional metal parts with cost-effective hybrid alternatives, even in critical applications. Additionally, Polymertal provides plating services and 3D object surface smoothing to enhance the performance and functionality of its products.

NanoScent

Grant in 2020
NanoScent is an Israeli sensor technology startup founded in 2017 that develops nanotechnology-based sensors for real-time detection of hydrogen impurities, gases, and volatile organic compounds. The company focuses on climate tech sensing and offers systems for monitoring hydrogen quality across the supply chain—from production to storage and refueling stations. Its flagship product, VOCID H2Confirm, provides in-line monitoring of hydrogen purity and VOCs with real-time alerts. NanoScent's technology supports applications in safety, quality control, and environmental monitoring. The company is headquartered in Misgav, Israel.

Indoor Robotics

Grant in 2020
Founded in 2018, Indoor Robotics designs and develops Tando, an AI-powered patrol drone for indoor security and inspection missions. Its unique features include independent AI-based navigation and patented ceiling docking, providing real-time coverage with predictive analysis to minimize false alarms.

SSH Communications Security

Grant in 2019
Founded in 1995, SSH Communications Security specializes in enterprise cybersecurity solutions. It offers products like PrivX for lean access management, Universal SSH Key Manager for key management, Tectia SSH for secure file transfer, and NQX Firewall for high-security applications. The company serves over 3000 customers globally, focusing on financial institutions and other organizations needing secure data access.

VAYAVISION

Grant in 2019
VayaVision Sensing Ltd. is a technology company that specializes in developing perception engine software aimed at enhancing the safety and efficiency of autonomous driving. Founded in 2016 and headquartered in Or Yehuda, Israel, the company offers VAYA-Drive, an artificial intelligence cognition platform that integrates raw data fusion with advanced computer vision techniques. This platform generates comprehensive environmental models, enabling critical functions such as road and free space detection, lane detection, object detection and tracking, and recognition of traffic signs. By utilizing deep learning algorithms, VayaVision delivers a reliable detection and classification system that accurately assesses the size, shape, and velocity of surrounding objects, including small obstacles. This innovative approach not only improves sensing capabilities for autonomous vehicles but also contributes to cost reductions within the automotive industry. Since July 2020, VayaVision has operated as a subsidiary of LeddarTech Inc.

OncoHost

OncoHost is a clinical-stage biotechnology company based in Binyamina, Israel, focused on developing personalized strategies to enhance the efficacy of cancer therapies. Founded in 2017, the company leverages proprietary proteomic analysis to gain insights into individual patient responses to treatment, addressing the significant challenge of therapy resistance in oncology. By analyzing proteomic changes in blood samples, OncoHost's platform facilitates the early identification of patients likely to be non-responsive to cancer treatments and aids in discovering new drug targets. This innovative approach combines bioinformatics, systems biology, and machine learning to provide healthcare institutions with critical information regarding predicted clinical benefits from therapies, ultimately enabling the development of tailored treatment strategies that aim to improve patient outcomes and minimize side effects. Through extensive clinical programs in collaboration with leading academic and clinical partners, OncoHost positions itself at the forefront of precision cancer medicine.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.